Ann E. Hunter

Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · Journal of Clinical Oncology · 2013 · 415 citations · Full text

Medicine, Oncology, Pharmacology +16

Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia

Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · Journal of Clinical Oncology · 2012 · 408 citations · Full text

Medicine, Oncology, Pharmacology +16

Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Anna Sureda, Stephen Robinson, Carmen Canals et al. · Journal of Clinical Oncology · 2007 · 318 citations · Full text

Medicine, Hematology, Oncology +16

The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison

Alan K. Burnett, Robert K. Hills, Ann E. Hunter et al. · Leukemia · 2012 · 159 citations · Full text

Medicine, Hematology, Pharmacology +9

T-Cell–Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma

Kirsty Thomson, Emma Morris, Don Milligan et al. · Journal of Clinical Oncology · 2010 · 135 citations · Full text

Medicine, Hematology, Oncology +16